Martin R. Turner

Martin R. Turner's AcademicInfluence.com Rankings

Martin R. Turner

Biology

#12310

World Rank

#15778

Historical Rank

Neuroscience

#2056

World Rank

#2113

Historical Rank

biology Degrees

Download Badge

Biology

Martin R. Turner's Degrees

Masters Biology University of Oxford
Bachelors Psychology University of Oxford

Similar Degrees You Can Earn

Why Is Martin R. Turner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Martin R. Turner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Amyotrophic lateral sclerosis (2011) (1550)
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study (2020) (908)
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study (2004) (648)
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria (2017) (511)
Controversies and priorities in amyotrophic lateral sclerosis (2013) (462)
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene (2018) (414)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. (2019) (379)
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model (2018) (276)
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration (2008) (274)
Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis (2010) (263)
A proposed staging system for amyotrophic lateral sclerosis (2012) (263)
Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers (2016) (249)
Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner (2011) (242)
Biomarkers in amyotrophic lateral sclerosis (2009) (231)
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. (2011) (231)
Neurofilament light chain (2015) (222)
Early symptom progression rate is related to ALS outcome: a prospective population-based study. (2002) (212)
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry (2017) (209)
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis (2016) (195)
Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations (2010) (185)
C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell‐Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (2016) (178)
Inflammation and neurovascular changes in amyotrophic lateral sclerosis (2013) (176)
A proposal for new diagnostic criteria for ALS (2020) (171)
Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis (2017) (167)
Neuroimaging in amyotrophic lateral sclerosis. (2012) (162)
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis (2011) (159)
The sex ratio in amyotrophic lateral sclerosis: A population based study (2010) (152)
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis (2013) (148)
A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis (2016) (148)
Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. (2006) (147)
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. (2005) (146)
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis (2014) (145)
Autoimmune disease preceding amyotrophic lateral sclerosis (2013) (144)
Quantifying Disease Progression in Amyotrophic Lateral Sclerosis (2014) (136)
Prolonged survival in motor neuron disease: a descriptive study of the King’s database 1990–2002 (2003) (135)
Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies (2009) (134)
Progressive encephalomyelitis with rigidity and myoclonus (2011) (128)
Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? (2012) (126)
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial (2013) (125)
CSF neurofilament light chain reflects corticospinal tract degeneration in ALS (2015) (122)
Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis (2010) (122)
Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. (2011) (121)
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis (2018) (119)
C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia (2017) (118)
Identification of distinct circulating exosomes in Parkinson's disease (2015) (108)
The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey (2015) (107)
Improving clinical trial outcomes in amyotrophic lateral sclerosis (2020) (103)
UK-Wide Surveillance of Neurological and Neuropsychiatric Complications of COVID-19: The First 153 Patients (2020) (103)
Advances in motor neurone disease (2014) (101)
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. (2005) (100)
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials (2019) (99)
Defective cholesterol metabolism in amyotrophic lateral sclerosis[S] (2016) (98)
Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale (2014) (97)
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis (2018) (94)
Genetic screening in sporadic ALS and FTD (2017) (93)
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations (2011) (91)
The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis (2017) (90)
Mimics and chameleons in motor neurone disease (2013) (89)
Assessment of the upper motor neuron in amyotrophic lateral sclerosis (2016) (85)
Primary lateral sclerosis: consensus diagnostic criteria (2020) (83)
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS (2012) (82)
Amyotrophic lateral sclerosis in an urban setting (2006) (82)
The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis (2010) (81)
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS (2016) (80)
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases (2010) (79)
Towards a TDP-43-Based Biomarker for ALS and FTLD (2018) (78)
Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains (2017) (78)
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials (2014) (78)
Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk (2016) (77)
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS (2005) (76)
Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study (2014) (76)
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. (2013) (76)
The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset (2016) (73)
Some difficult decisions in ALS/MND (2010) (73)
Pattern of spread and prognosis in lower limb-onset ALS (2010) (69)
Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study (2011) (68)
Young-onset amyotrophic lateral sclerosis: historical and other observations. (2012) (64)
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis (2019) (64)
Advances in the application of MRI to amyotrophic lateral sclerosis. (2010) (63)
What Does Imaging Reveal About the Pathology of Amyotrophic Lateral Sclerosis? (2015) (63)
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis (2016) (62)
Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks (2016) (61)
ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function (2018) (60)
Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability (2011) (60)
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease (2016) (60)
Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS (2013) (59)
Myelin imaging in amyotrophic and primary lateral sclerosis (2013) (59)
Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. (2012) (59)
Head and other physical trauma requiring hospitalisation is not a significant risk factor in the development of ALS (2010) (58)
Mind the gap: The mismatch between clinical and imaging metrics in ALS (2015) (56)
Altered cortical beta‐band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis (2016) (56)
Defining causality in COVID-19 and neurological disorders (2020) (55)
Mills’ and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET (2005) (54)
Apathy is associated with poor prognosis in amyotrophic lateral sclerosis (2016) (54)
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis (2021) (52)
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: An (11C)‐flumazenil PET study (2008) (51)
DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial. (2016) (51)
Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis (2007) (51)
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers (2021) (50)
Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis (2014) (50)
Multiple Kernel Learning Captures a Systems-Level Functional Connectivity Biomarker Signature in Amyotrophic Lateral Sclerosis (2013) (49)
Cortical involvement in four cases of primary lateral sclerosis using [11C]-flumazenil PET (2007) (48)
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis (2014) (48)
Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis. (2009) (46)
Differential corticospinal tract degeneration in homozygous ‘D90A’ SOD-1 ALS and sporadic ALS (2011) (45)
Clinical trials in ALS: an overview. (2001) (45)
CSF chitinase proteins in amyotrophic lateral sclerosis (2019) (45)
Tools and talk: An evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis (2014) (44)
Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource (2017) (44)
Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis (2019) (43)
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology (2018) (43)
Psychiatric disorders prior to amyotrophic lateral sclerosis (2016) (43)
Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis (2003) (41)
Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis (2015) (41)
Large-scale pathways-based association study in amyotrophic lateral sclerosis. (2007) (41)
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson’s disease and epilepsy in English populations 1979–2006 (2010) (40)
Geographical Clustering of Amyotrophic Lateral Sclerosis in South-East England: A Population Study (2008) (40)
The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis (2015) (39)
Defining pre-symptomatic amyotrophic lateral sclerosis (2019) (39)
Amyotrophic lateral sclerosis and cancer: A register-based study in Sweden (2013) (39)
Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis (2018) (38)
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation (2018) (38)
The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison (2017) (35)
C ]-WAY 100635 PET demonstrates marked 5-HT 1 A receptor changes in sporadic ALS (1985) (33)
Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis (2015) (32)
Methods for quantitative susceptibility and R2* mapping in whole post-mortem brains at 7T applied to amyotrophic lateral sclerosis (2020) (31)
Magnetoencephalography (2014) (30)
Amyotrophic lateral sclerosis: the complex path to precision medicine (2018) (29)
T2-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS (2014) (28)
Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis (2017) (28)
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis (2014) (28)
Increased premorbid physical activity and amyotrophic lateral sclerosis: born to run rather than run to death, or a seductive myth? (2013) (28)
Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen (2001) (27)
A case of celiac disease mimicking amyotrophic lateral sclerosis (2007) (27)
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis (2021) (27)
A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis (2017) (27)
Impaired corticomuscular and interhemispheric cortical beta oscillation coupling in amyotrophic lateral sclerosis (2018) (27)
Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair (2019) (27)
Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS (2007) (27)
Relative preservation of triceps over biceps strength in upper limb-onset ALS: the ‘split elbow’ (2019) (26)
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis (2014) (25)
UFLC‐Derived CSF Extracellular Vesicle Origin and Proteome (2018) (25)
Imaging: MRS/MRI/PET/SPECT: Summary (2002) (24)
Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level? (2013) (24)
An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress (2020) (23)
Comparison of two percutaneous radiological gastrostomy tubes in the nutritional management of ALS patients (2005) (23)
Cerebellar tract alterations in PLS and ALS (2019) (23)
Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis (2020) (23)
MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers? (2011) (22)
Management of sialorrhoea in motor neuron disease: A survey of current UK practice (2013) (22)
Imaging as a biomarker in drug discovery for Alzheimer’s disease: is MRI a suitable technology? (2014) (22)
Measurement of change (2009) (22)
Reduced cancer incidence in Huntington's disease: record linkage study clue to an evolutionary trade‐off? (2013) (20)
Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis (2020) (20)
An Eye-Tracking Version of the Trail-Making Test (2013) (20)
The association between ALS and population density: A population based study (2010) (20)
CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis (2020) (20)
Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis. (2010) (20)
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis (2020) (19)
Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP (2020) (19)
Voxel-Based MRI Intensitometry Reveals Extent of Cerebral White Matter Pathology in Amyotrophic Lateral Sclerosis (2014) (19)
Quantitative patterns of motor cortex proteinopathy across ALS genotypes (2020) (19)
Increased cerebral functional connectivity in ALS (2018) (18)
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases (2021) (18)
Positron emission tomography (PET) – its potential to provide surrogate markers in ALS (2000) (17)
Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis (2014) (17)
Frequency and signature of somatic variants in 1461 human brain exomes (2018) (17)
A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS (2017) (17)
Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis (2018) (17)
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) in the older adult (2014) (17)
The internet for self-diagnosis and prognostication in ALS (2010) (16)
Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains (2018) (16)
Oxford textbook of neuromuscular disorders (2014) (16)
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study (2021) (16)
Kiernan and others 2011 Amyotrophic Lateral Sclerosis - Review Article (2011) (16)
Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study (2019) (15)
Does dysfunction of the mirror neuron system contribute to symptoms in amyotrophic lateral sclerosis? (2015) (14)
Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis (2020) (13)
Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis (2012) (13)
Neuroimaging in primary lateral sclerosis (2020) (13)
Diagnosis: is it motor neuron disease? (2009) (12)
Tracheostomy in motor neurone disease (2019) (12)
Wasp sting induced autoimmune neuromyotonia (2006) (12)
Exploring the Feasibility of Using Biotelemetry to Monitor Patients with Amyotrophic Lateral Sclerosis During Clinical Trials (Preprint) (2019) (12)
Tensor Image Registration Library: Automated Non-Linear Registration of Sparsely Sampled Histological Specimens to Post-Mortem MRI of the Whole Human Brain (2019) (11)
Are neurofilaments heading for the ALS clinic? (2015) (11)
The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder (2014) (11)
Epilepsy and the subsequent risk of cerebral tumour: record linkage retrospective cohort study (2011) (11)
Primary lateral sclerosis: diagnosis and management (2020) (11)
The Brain: A Beginner's Guide (2005) (10)
Positron emission tomography (PET)--its potential to provide surrogate markers in ALS. (2000) (10)
A novel central motor conduction abnormality in D90A‐homozygous patients with amyotrophic lateral sclerosis (2004) (10)
Improving access to medicines: empowering patients in the quest to improve treatment for rare lethal diseases (2013) (10)
Evolution of white matter damage in amyotrophic lateral sclerosis (2020) (10)
Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis (2012) (10)
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis (2021) (9)
Diffusion Tensor Imaging in Sporadic and Familial ( D 90 A SOD 1 ) Forms of Amyotrophic Lateral Sclerosis (2008) (9)
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study (2020) (9)
Microvasculitic paraproteinaemic polyneuropathy and B‐cell lymphoma (2003) (9)
Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis. (2018) (9)
Swallowing and oropharyngeal dysphagia. (2014) (9)
Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis (2018) (9)
A wider pathological network underlying breathlessness and respiratory failure in amyotrophic lateral sclerosis (2016) (9)
Catastrophic hyperkalaemia following administration of suxamethonium chloride to a patient with undiagnosed amyotrophic lateral sclerosis. (2011) (9)
Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease (2016) (9)
A multi-center study of neurofilament assay reliability and inter-laboratory variability (2020) (9)
Genetic testing in motor neurone disease (2022) (9)
The borderland of neuromyelitis optica (2009) (8)
The treatment of motor neurone disease. (2001) (8)
Epigenetic signatures and early detection of neurodegenerative diseases: Development of stratifying biomarkers for amyotrophic lateral sclerosis in Asian cohorts (2017) (8)
Progressive hemiparesis in a 75-year-old man (2014) (7)
What is the place of thrombolysis in acute stroke? A review of the literature and a current perspective. (2008) (7)
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis (2022) (7)
Public awareness of motor neuron disease (2010) (7)
The tough body at the epicentre of amyotrophic lateral sclerosis (2016) (7)
Reversible diffusion MRI abnormalities and transient mutism after liver transplantation (2005) (6)
Characterising neuropsychiatric disorders in patients with COVID-19 – Authors' reply (2020) (6)
Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy (2013) (6)
Motor neurone disease is a clinical diagnosis (2012) (6)
Cephalosporin-induced myoclonus (2006) (6)
The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis (2020) (6)
Erratum to: Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains (2017) (6)
Therapeutic non-invasive brain stimulation in amyotrophic lateral sclerosis: rationale, methods and experience (2019) (5)
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain (2022) (5)
Motor neuron disease: biomarker development for an expanding cerebral syndrome. (2016) (5)
Teaching Video NeuroImages: Acute Adie syndrome (2012) (5)
Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology (2020) (5)
Chapter 21 Disease-Modifying Therapies in Motor Neuron Disorders: The Present Position and Potential Future Developments (2003) (5)
The Digital Brain Bank, an open access platform for post-mortem imaging datasets (2022) (5)
The reunification of amyotrophic lateral sclerosis (2018) (5)
The clinical spectrum of primary lateral sclerosis (2020) (5)
Increased cerebral functional connectivity in ALS A resting-state magnetoencephalography study (5)
Preface: promoting research in PLS: current knowledge and future challenges (2020) (4)
Lou Gehrig and the ALS split hand (2015) (4)
Teaching Neuroimages: Hypometabolism of the primary motor cortex in primary lateral sclerosis: The stripe sign (2016) (4)
Neurophysiological features of primary lateral sclerosis (2020) (4)
Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis (2015) (4)
The Digital Brain Bank, an open access platform for post-mortem datasets (2021) (4)
Child Neurology: A growing skull fracture (2009) (3)
Sweet food preference in amyotrophic lateral sclerosis (2017) (3)
Is cardiovascular fitness a risk factor for ALS? (2017) (3)
SEASONAL VARIATION, SUB–TYPE AND PRODROMAL ILLNESSES IN GUILLAIN–BARRE SYNDROME (2013) (3)
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD) (2017) (3)
Nutritional pathway for people with motor neurone disease. (2016) (3)
Riluzole and Motor Neurone Disease (2003) (3)
Teaching NeuroImages: Somatic muscle fasciculations detected by electrocardiography (2012) (3)
Untangling neuroinflammation in amyotrophic lateral sclerosis (2019) (3)
A resistant case of spontaneous intracranial hypotension (2008) (3)
Promoting clinical and patient-oriented research to identify the pathogenesis of amyotrophic lateral sclerosis (2013) (3)
Diagnosing ALS: the Gold Coast criteria and the role of EMG (2022) (3)
The Duty to Look for Incidental Findings in Imaging Research. (2020) (3)
Kinnier Wilson’s puzzling features of amyotrophic lateral sclerosis (2017) (3)
Progressive dysphagia without dysarthria (2013) (3)
Prediction of personalised prognosis in patients with amyotrophic lateral sclerosis: development and validation of a prediction model (2018) (3)
Comprar Motor Neuron Disease. A Practical Manual (Oxford Care Manuals) | Kevin Talbot | 9780199547364 | Oxford University Press (2010) (2)
hexanucleotide expansions are associated with altered ER calcium homeostasis and stress granule formation in iPSC-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia (2016) (2)
Atypical TDP‐43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBP (2022) (2)
Romberg's test no longer stands up (2016) (2)
Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients (2022) (2)
Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis (2022) (2)
Unilateral leukonychia and hair depigmentation in multifocal motor neuropathy (2013) (2)
Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALS (2021) (2)
The early biomarker challenge in neurodegenerative disorders (2019) (2)
Clinical characteristics of participants. (2014) (2)
Modelling seeding and neuroanatomic spread of pathology in amyotrophic lateral sclerosis (2021) (2)
Eliciting the history (2014) (2)
The upper motor neuron syndrome in amyotrophic lateral sclerosis (2020) (2)
Faulty brakes : An inhibitory neuronal deficit in the pathogenesis of motor neuron disease (2012) (2)
Evaluation of a Health State Staging System Defined by Loss of Independence in Amyotrophic Lateral Sclerosis: Assessment in a Second Dataset (2013) (1)
Dipeptide Repeat Pathology in C9orf72-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway Imbalance (2022) (1)
The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases (2023) (1)
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis (2014) (1)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis (1)
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology (2018) (1)
Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts (2022) (1)
Cerebrospinal fluid-based biomarkers for amyotrophic lateral sclerosis (2012) (1)
Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal. (2022) (1)
The wisdom of neurologists (2013) (1)
Isolated homozygous R217X OPTN mutation causes knock-out of functional C-terminal optineurin domains and associated oligodendrogliopathy-dominant ALS–TDP (2021) (1)
PATH44 Corpus callosum diffusion tensor imaging as a biomarker for motor neurone disease (2010) (1)
Clinical trials in pediatric ALS: a TRICALS feasibility study (2022) (1)
REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis (2020) (1)
Peer recommendations on how to improve clinical research, and Conference wrap-up (2013) (1)
Modeling seeding and neuroanatomic spread of pathology in amyotrophic lateral sclerosis (2022) (1)
SPECT in dementia, schizophrenia and other psychiatric disorders (1997) (1)
CARERS AND FAMILIES (2007) (1)
A nudge towards better lumbar puncture practice. (2020) (1)
Motor neuron disease (2018) (1)
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis (2022) (1)
Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System (2013) (1)
Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly (2010) (1)
To Zoom or Not to Zoom: The Should I Travel Index Revisited during the Coronavirus Disease Pandemic (2021) (1)
Non-invasive in vivo neuropathology of the C9orf72-related ALS-FTD syndrome (2017) (1)
Widespread cerebral cavernous haemangiomata found after 24 years of intermittent symptoms (2001) (1)
Human iPSC co-culture model to investigate the interaction between microglia and motor neurons (2022) (1)
Background: understanding motor neuron disease (2009) (1)
Imaging as a biomarker in drug discovery for Alzheimer’s disease: is MRI a suitable technology? (2014) (1)
Understanding living with tracheostomy ventilation for motor neuron disease and the implications for quality of life: a qualitative study protocol (2023) (0)
Focal precentral gyrus involvement in osmotic demyelination (2017) (0)
Stop pacing patient letter (diaphragm pacing arm) (2016) (0)
A Data-Driven Characterisation of the Evolution of White Matter Damage in Amyotrophic Lateral Sclerosis (2020) (0)
Reply to: Early white matter changes on diffusion tensor imaging in amyotrophic lateral sclerosis (2020) (0)
Theme 10 Disease stratification and phenotyping of patients (2019) (0)
Stop pacing general practitioner cover letter (diaphragm pacing arm) (2016) (0)
ID 231 – Multicentric structural connectome analysis in 240 patients with amyotrophic lateral sclerosis (2016) (0)
Patient information sheet: patient (2016) (0)
Clinic letters revisited (2019) (0)
Other motor neuron disorders (2009) (0)
Mutations in ANXA11 cause familial and sporadic amyotrophic lateral sclerosis (2017) (0)
Rutter-Locher 1 Full Title: Analysis of the terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease Running title: Analysis of terms used for amyotrophic lateral sclerosis (0)
CNS-TARGETED METHYLPREDNISOLONE REDUCES PATHOLOGY IN MOUSE MODEL OF ALS (2013) (0)
Altered cerebral functional connectivity in pre-symptomatic individuals at risk for ALS (2015) (0)
Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis (2021) (0)
Quantitative patterns of motor cortex proteinopathy across ALS genotypes (2020) (0)
Thrombolysis for ischaemic stroke. Authors' reply (2008) (0)
Grand rounds: a precious resource to be nurtured (2020) (0)
S67: 25 years of neuroimaging in amyotrophic lateral sclerosis (2014) (0)
Pineal gland as the source of the soul and third eye (2021) (0)
Evidence of defective cholesterol metabolism in ALS (2016) (0)
End-of-life issues (2009) (0)
Pre-Symptomatic Loss Of Cerebral White Matter Integrity In Those At Genetic Risk Of Amyotrophic Lateral Sclerosis (S26.004) (2014) (0)
Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data (2013) (0)
Consent form: carer qualitative (2016) (0)
169 Antisaccade task as a biomarker in MND (2012) (0)
Progress in the Quest to Prevent Huntington Disease (2014) (0)
Genetics of MND (2009) (0)
PATU5 Characterisation of fused in sarcoma pathology and FUS mutations in juvenile amyotrophic lateral sclerosis with basophilic inclusions (2010) (0)
Cortical localisation of neuropsychological impairment in amyotrophic lateral sclerosis (ALS): An [C-11] Flumazenil PET study (2005) (0)
Defective cholesterol metabolism in amyotrophic lateral sclerosis patient-oriented and epidemiological (2019) (0)
1118 Are MND patients pre-morbidly fitter? Indirect evidence from hospital record-linkage (2012) (0)
A sting in the tale - A unique case of wasp induced autoimmune neuromyotonia (2005) (0)
Potential disease-modifying therapies (2009) (0)
017 Widespread extra-motor abnormality is a prominent MRI signature of ALS: a cross-cohort study (2019) (0)
004 A triaging blood test for neurology? Serum neurofilament levels in a cohort of GP referrals (2019) (0)
Management of respiratory symptoms (2009) (0)
Quantitative Analysis of FLAIR Images in ALS Has Diagnostic Potential (2012) (0)
071 Motor network remodelling in ALS and PLS (2022) (0)
Regression analysis of VBI-processed T1 intensities of all ALS patients and their ALSFRS-R. (2014) (0)
Motor neurone disease: not just motor and no longer one disease (2016) (0)
ABN news (2021) (0)
Capture of Functional Decline in International Phase III Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System (P07.074) (2013) (0)
Participant flow in each trial arm (2016) (0)
Patient information sheet: patient qualitative (2016) (0)
Fast Facts: Diagnosing Amyotrophic Lateral Sclerosis (2019) (0)
Corrigendum (2022) (0)
Changes in cortical β-oscillation dynamics across the clinical spectrum of motor neuron disease (2016) (0)
Electrical impedance myography as a biomarker for ALS – Author's reply (2009) (0)
Central motor conduction abnormalities in D90A homozygous familial amyotrophic lateral sclerosis (2007) (0)
Screening and randomisation (2016) (0)
267 Motor system biomarkers in amyotrophic lateral sclerosis (2019) (0)
MND plus (2019) (0)
A RISK-STRATIFYING TOOL TO ENABLE LATE-STAGE PEG INSERTION IN MND (2016) (0)
Neurogastroentrology: an A to Z (2011) (0)
Multi-component relaxation reveals distinct patterns of white matter involvement in primary progressive multiple sclerosis and primary lateral sclerosis (2012) (0)
Diffusion tensor imaging reveals white matter differences between sporadic and familial forms of amyotrophic lateral sclerosis (2008) (0)
Delayed recovery of ulnar neuropathy due to elbow warming (2005) (0)
Multicenter analysis of the structural connectome in amyotrophic lateral sclerosis in > 250 patients (2015) (0)
Neuroimaging in the Management of Motor Neuron Diseases (2011) (0)
MN11 C9ORF72 and RAB7L1 regulate vesicle traffi cking in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (2017) (0)
CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis (2020) (0)
Episodic hypothermia with mutism in an older woman (2008) (0)
Stop pacing patient letter (non-invasive ventilation arm) (2016) (0)
Imaging in Motor Neuron Disease (2014) (0)
OXFORD MOTOR NEURONE DISORDERS RESEARCH (2010) (0)
Patient information sheet: carer qualitative (2016) (0)
Magnetoencephalographic evidence of cortical motor dysfunction in ALS (2014) (0)
Qualitative interview topic guide (2016) (0)
V15. Ex post facto structural connectome analysis in ALS at multicenter level: Analysis of over 400 data sets from 8 centers (2015) (0)
P89 An MRI biomarker for motor neuron disease? (2010) (0)
Turner and others 2013 Controversies and priorities in Amyotrophic Lateral Sclerosis (2013) (0)
Consent form: carer (2016) (0)
PORT02 Oxford motor neurone disorders research (2010) (0)
Pacing discontinuation standard operating procedure (2016) (0)
The interactome of human TDP-43 in a cellular model of amyotrophic lateral sclerosis (2019) (0)
Natural history of motor neuron disease (2009) (0)
The Role of Neuroimaging in Amyotrophic Lateral Sclerosis (2015) (0)
FUS pathology and FUS mutations characterize juvenile ALS with basophilic inclusions (2010) (0)
012 Volumetric and connectivity profile of regional thalamic abnormality in amyotrophic lateral sclerosis (2021) (0)
Explorer A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis (2016) (0)
Author Index (2018) (0)
Treatable Mills syndrome: A unique case of coeliac disease mimicking motor neurone disease (2007) (0)
Title: Mutations in ANXA11 cause familial and sporadic amyotrophic lateral sclerosis (2016) (0)
Preface to ‘Neuromythology’ (2016) (0)
A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planning. (2022) (0)
Teaching Video NeuroImage:The “Fonzarelli” sign (2008) (0)
Consent form: patient qualitative (2016) (0)
Patient information sheet: carer (2016) (0)
Chasing the Trace (2014) (0)
Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains (2017) (0)
An apparently non-maternally inherited syndrome of seizures, ataxia and ophthalmoplegia, with distinctive cerebellar lesions, in an Irish pedigree (2005) (0)
Manji H, Wills A, Dorward N, Kitchen N, Connelly S, Mehta A, editors. The Oxford handbook of neurology. Oxford University Press; 2007, £29.95 (Amazon), ISBN-13: 978-0198509738 (2007) (0)
Control of Sigatoka disease with Delsene M 200 a new carbendazim/mancozeb fungicide (1979) (0)
Human iPSC co-culture model to investigate the interaction between microglia and motor neurons (2022) (0)
POD12 Development of a hands-free, eye-tracking version of the Trail Making Test (2010) (0)
Book Reviews (2011) (0)
Organization of MND services (2009) (0)
An elusive cause for a progressive neuropathy (2013) (0)
Frequency and signature of somatic variants in 1461 human brain exomes (2018) (0)
Amyotrophic lateral sclerosis in an urban setting A population based (2007) (0)
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis (2016) (0)
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation (2018) (0)
707: REVEAL Registry: Comparison of Functional Status in Adult PAH Patients with and without Comorbid Medical Conditions (2009) (0)
Tensor image registration library: Deformable registration of stand‐alone histology images to whole‐brain post‐mortem MRI data (2022) (0)
Platform Communications (2018) (0)
Label-free fibre optic Raman spectroscopy with bounded simplex-structured matrix factorization for the serial study of serum in amyotrophic lateral sclerosis (2022) (0)
Tensor Image Registration Library: Automated Deformable Registration of Stand-Alone Histology Images to Whole-Brain Post-Mortem MRI Data (2022) (0)
Towards a TDP-43-Based Biomarker for ALS and FTLD (2018) (0)
Consent form: patient (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Martin R. Turner?

Martin R. Turner is affiliated with the following schools:

University of Oxford

Martin R. Turner's Academic­Influence.com Rankings